Shehroo B Pudumjee1, Emily S Lundt2, Sabrina M Albertson2, Mary M Machulda1, Walter K Kremers2, Clifford R Jack3, David S Knopman4, Ronald C Petersen5, Michelle M Mielke4,5, Nikki H Stricker1. 1. Division of Neurocognitive Disorders, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. 2. Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. 3. Department of Radiology, Mayo Clinic, Rochester, MN, USA. 4. Department of Neurology, Mayo Clinic, Rochester, MN, USA. 5. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Abstract
BACKGROUND: Longitudinal, but not cross-sectional, cognitive testing is one option proposed to define transitional cognitive decline for individuals on the Alzheimer's disease continuum. OBJECTIVE: Compare diagnostic accuracy of cross-sectional subtle objective cognitive impairment (sOBJ) and longitudinal objective decline (ΔOBJ) over 30 months for identifying 1) cognitively unimpaired participants with preclinical Alzheimer's disease defined by elevated brain amyloid and tau (A+T+) and 2) incident mild cognitive impairment (MCI) based on Cogstate One Card Learning (OCL) accuracy performance. METHODS: Mayo Clinic Study of Aging cognitively unimpaired participants aged 50 + with amyloid and tau PET scans (n = 311) comprised the biomarker-defined sample. A case-control sample of participants aged 65 + remaining cognitively unimpaired for at least 30 months included 64 who subsequently developed MCI (incident MCI cases) and 184 controls, risk-set matched by age, sex, education, and visit number. sOBJ was assessed by OCL z-scores. ΔOBJ was assessed using within subjects' standard deviation and annualized change from linear regression or linear mixed effects (LME) models. Concordance measures Area Under the ROC Curve (AUC) or C-statistic and odds ratios (OR) from conditional logistic regression models were derived. sOBJ and ΔOBJ were modeled jointly to compare methods. RESULTS: sOBJ and ΔOBJ-LME methods differentiated A+T+ from A-T- (AUC = 0.64, 0.69) and controls from incident MCI (C-statistic = 0.59, 0.69) better than chance; other ΔOBJ methods did not. ΔOBJ-LME improved prediction of future MCI over baseline sOBJ (p = 0.003) but not over 30-month sOBJ (p = 0.09). CONCLUSION: Longitudinal decline did not offer substantial benefit over cross-sectional assessment in detecting preclinical Alzheimer's disease or incident MCI.
BACKGROUND: Longitudinal, but not cross-sectional, cognitive testing is one option proposed to define transitional cognitive decline for individuals on the Alzheimer's disease continuum. OBJECTIVE: Compare diagnostic accuracy of cross-sectional subtle objective cognitive impairment (sOBJ) and longitudinal objective decline (ΔOBJ) over 30 months for identifying 1) cognitively unimpaired participants with preclinical Alzheimer's disease defined by elevated brain amyloid and tau (A+T+) and 2) incident mild cognitive impairment (MCI) based on Cogstate One Card Learning (OCL) accuracy performance. METHODS: Mayo Clinic Study of Aging cognitively unimpaired participants aged 50 + with amyloid and tau PET scans (n = 311) comprised the biomarker-defined sample. A case-control sample of participants aged 65 + remaining cognitively unimpaired for at least 30 months included 64 who subsequently developed MCI (incident MCI cases) and 184 controls, risk-set matched by age, sex, education, and visit number. sOBJ was assessed by OCL z-scores. ΔOBJ was assessed using within subjects' standard deviation and annualized change from linear regression or linear mixed effects (LME) models. Concordance measures Area Under the ROC Curve (AUC) or C-statistic and odds ratios (OR) from conditional logistic regression models were derived. sOBJ and ΔOBJ were modeled jointly to compare methods. RESULTS: sOBJ and ΔOBJ-LME methods differentiated A+T+ from A-T- (AUC = 0.64, 0.69) and controls from incident MCI (C-statistic = 0.59, 0.69) better than chance; other ΔOBJ methods did not. ΔOBJ-LME improved prediction of future MCI over baseline sOBJ (p = 0.003) but not over 30-month sOBJ (p = 0.09). CONCLUSION: Longitudinal decline did not offer substantial benefit over cross-sectional assessment in detecting preclinical Alzheimer's disease or incident MCI.
Authors: David G Darby; Robert H Pietrzak; Julia Fredrickson; Michael Woodward; Lynette Moore; Amy Fredrickson; Jack Sach; Paul Maruff Journal: Alzheimers Dement Date: 2012 Impact factor: 21.566
Authors: Mary M Machulda; Emily S Lundt; Sabrina M Albertson; Walter K Kremers; Michelle M Mielke; David S Knopman; Mark W Bondi; Ronald C Petersen Journal: Alzheimers Dement Date: 2019-05-23 Impact factor: 21.566
Authors: Christopher C Rowe; Pierrick Bourgeat; Kathryn A Ellis; Belinda Brown; Yen Ying Lim; Rachel Mulligan; Gareth Jones; Paul Maruff; Michael Woodward; Roger Price; Peter Robins; Henri Tochon-Danguy; Graeme O'Keefe; Kerryn E Pike; Paul Yates; Cassandra Szoeke; Olivier Salvado; S Lance Macaulay; Timothy O'Meara; Richard Head; Lynne Cobiac; Greg Savage; Ralph Martins; Colin L Masters; David Ames; Victor L Villemagne Journal: Ann Neurol Date: 2013-12 Impact factor: 10.422
Authors: David S Knopman; Emily S Lundt; Terry M Therneau; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Mary M Machulda; Bradley F Boeve; David T Jones; Jon Graff-Radford; Sabrina M Albertson; Christopher G Schwarz; Ronald C Petersen; Clifford R Jack Journal: Brain Date: 2019-04-01 Impact factor: 13.501
Authors: David G Darby; Amy Brodtmann; Robert H Pietrzak; Julia Fredrickson; Michael Woodward; Victor L Villemagne; Amy Fredrickson; Paul Maruff; Christopher Rowe Journal: J Alzheimers Dis Date: 2011 Impact factor: 4.472
Authors: Prashanthi Vemuri; Val J Lowe; David S Knopman; Matthew L Senjem; Bradley J Kemp; Christopher G Schwarz; Scott A Przybelski; Mary M Machulda; Ronald C Petersen; Clifford R Jack Journal: Alzheimers Dement (Amst) Date: 2016-12-21
Authors: Kelsey R Thomas; Katherine J Bangen; Alexandra J Weigand; Emily C Edmonds; Christina G Wong; Shanna Cooper; Lisa Delano-Wood; Mark W Bondi Journal: Neurology Date: 2019-12-30 Impact factor: 11.800
Authors: Anna H Noel-Storr; Jenny M McCleery; Edo Richard; Craig W Ritchie; Leon Flicker; Sarah J Cullum; Daniel Davis; Terence J Quinn; Chris Hyde; Anne W S Rutjes; Nadja Smailagic; Sue Marcus; Sandra Black; Kaj Blennow; Carol Brayne; Mario Fiorivanti; Julene K Johnson; Sascha Köpke; Lon S Schneider; Andrew Simmons; Niklas Mattsson; Henrik Zetterberg; Patrick M M Bossuyt; Gordon Wilcock; Rupert McShane Journal: Neurology Date: 2014-06-18 Impact factor: 9.910